US Stock MarketDetailed Quotes

ABVX Abivax S.A.

Watchlist
  • 14.000
  • +0.660+4.95%
Close May 31 16:00 ET
880.69MMarket Cap-3768P/E (TTM)

Abivax S.A. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Abivax S.A. Earnings Date

Currency: EUR

Period

FY2023 Annual Report

Apr 2, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-3.43

-7.86%
Analyst Rating

Strong Buy

May 31, 2024

Abivax S.A. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Sep 9, 20242024/Q2-- / 1.123M--
--2024/Q1-- / 1.123M--
--2019/Q120.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
Sep 9, 20242024/Q2-- / 1.123M--
--2024/Q1-- / 1.123M--
--2019/Q120.000K / 0.000--

Abivax S.A. Earnings Reports

  • Abivax S.A. | 20-F: Registration statement / Annual report / Transition report

    Apr 5 15:12

  • Abivax S.A. | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 2 09:29

  • Abivax S.A. | 6-K: Report of foreign private issuer (related to financial reporting)

    Jan 21 23:00

    • Analysis

    Analyst Rating

    Updated: May 31, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg